This medication requires a valid prescription. Please refer to the ‘Prescription Guide’ for details.
Note: We can assist only if the medicine is unavailable in your country.”
Voranigo (vorasidenib)
General Description:
Voranigo (vorasidenib) is an oral prescription medication indicated for the treatment of adults and children aged 12 years and older with Grade 2 astrocytoma or oligodendroglioma. It works by selectively inhibiting mutant IDH1 and IDH2 enzymes, which play a role in tumor growth, helping to slow disease progression and improve patient outcomes.
Voranigo is administered orally as tablets, with dosage and treatment schedules determined by a qualified healthcare professional based on patient needs.
Getting Voranigo (vorasidenib) in India
Voranigo is currently approved by the FDA in the USA. While it may not yet be commercially available in India, patients can access it legally through a Named Patient Program (NPP) under the supervision of a licensed physician.
MitoGENE assists Indian patients in obtaining Voranigo safely, handling all regulatory approvals, import permits, and logistics to ensure a secure and compliant process.
Disease Indication:
• Head and Neck Cancer / Grade 2 Astrocytoma or Oligodendroglioma
Manufacturer:
Servier
Usage:
Oral Tablets
Medicine Approved By:
• Food and Drug Administration (FDA)
• European Medicines Agency (EMA)
Available Dosage Form & Package:
• A bottle with 30 tablets x 10 mg
• A bottle with 30 tablets x 40 mg
Shipping:
Room Temperature Shipping
Voranigo is shipped under controlled room temperature conditions (15–25°C) to maintain stability and effectiveness. Standard shipping procedures ensure the medication remains safe and uncompromised during transit.
How to Access Voranigo (vorasidenib) in India in 4 Simple Steps with MitoGENE via the Named Patient Program (NPP)?
If Voranigo (vorasidenib) is not yet approved or commercially available in India, MitoGENE can assist you in accessing it legally through the Named Patient Program (NPP). Here’s how the process works:
